These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4907517)

  • 1. Treatment of persistent phenothiazine-induced oral dyskinesia.
    Roxburgh PA
    Br J Psychiatry; 1970 Mar; 116(532):277-80. PubMed ID: 4907517
    [No Abstract]   [Full Text] [Related]  

  • 2. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK; Muzekari LH; Shanken PM
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained relief of hemiballismus.
    Rowlands IP
    Br Med J; 1972 Apr; 2(5808):296. PubMed ID: 4259962
    [No Abstract]   [Full Text] [Related]  

  • 4. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.
    Crane GE
    Am J Psychiatry; 1968 Feb; 124(8):Suppl:40-8. PubMed ID: 4865731
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
    Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
    Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistent phenothiazine dyskinesia treated with tetrabenazine.
    Godwin-Austen RB; Clark T
    Br Med J; 1971 Oct; 4(5778):25-6. PubMed ID: 4938245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent oral dyskinesia in female mental hospital patients.
    Pryce IG; Edwards H
    Br J Psychiatry; 1966 Oct; 112(491):983-7. PubMed ID: 5970925
    [No Abstract]   [Full Text] [Related]  

  • 9. Thiopropazate hydrochloride in persistent dyskinesia.
    Singer K; Cheng MN
    Br Med J; 1971 Oct; 4(5778):22-5. PubMed ID: 4938244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drug withdrawal on tardive dyskinesia.
    Crane GE; Ruiz P; Kernohan WJ; Wilson W; Royalty N
    Act Nerv Super (Praha); 1969; 11(1):30-5. PubMed ID: 5770140
    [No Abstract]   [Full Text] [Related]  

  • 11. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 12. The significance of brain damage in persistent oral dyskinesia.
    Edwards H
    Br J Psychiatry; 1970 Mar; 116(532):271-5. PubMed ID: 5418925
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenothiazine-induced dyskinesia in nursing-home patients.
    Greenblatt DL; Dominick JR; Stotsky BA; DiMascio A
    J Am Geriatr Soc; 1968 Jan; 16(1):27-34. PubMed ID: 4863733
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiopropazate hydrochloride in persistent dyskinesia.
    Singer K; Cheng MN
    Br Med J; 1971 Dec; 4(5787):626. PubMed ID: 5167074
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children.
    McAndrew JB; Case Q; Treffert DA
    J Autism Child Schizophr; 1972; 2(1):75-91. PubMed ID: 5067403
    [No Abstract]   [Full Text] [Related]  

  • 16. [Persistent extrapyramidal oral dyskinesia following administration of thymoleptics].
    Sedivec V; Valenová Z; Paceltová L
    Cesk Psychiatr; 1969 Aug; 65(4):241-4. PubMed ID: 5807247
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent dyskinesia.
    Crane GE
    Br J Psychiatry; 1973 Apr; 122(569):395-405. PubMed ID: 4577946
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of lobotomized schizophrenic patients with butaperazine.
    Holden JM; Itil TM; Keskiner A
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):418-28. PubMed ID: 4390417
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 20. [First clinical trails with the "medium tranquilizer" mesoridazine].
    Rhomberg F; Staehelin B
    Schweiz Med Wochenschr; 1967 Apr; 97(16):521-5. PubMed ID: 4875573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.